Clover Health Investments, Corp. reported strong financial results for the first quarter of 2025 on May 6, 2025. Insurance revenue for Q1 2025 was $462.3 million, representing a 33.7% increase year-over-year.
The company achieved Adjusted EBITDA of $25.8 million in Q1 2025, a significant improvement from a loss of $14.9 million in Q1 2024. This demonstrates Clover's ability to grow membership and expand profitability through its differentiated model and Clover Assistant technology.
Clover Health improved its full-year 2025 guidance, now expecting Adjusted EBITDA between $50 million and $70 million. The company also highlighted recent clinical whitepaper findings showing 18% lower hospitalizations and 25% lower readmissions for CHF patients whose PCPs use Clover Assistant.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.